Field Study to evaluate the activity of a site specific B-Domain Deleted (BDD) pegylated recombinant FVIII protein (BAY 94-9027) in plasma samples measured with both chromogenic and one stage assays used in clinical laboratories
|Effective start/end date||10/20/15 → 6/30/16|
- BAYER HEALTHCARE LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.